Headquarters
3012 ROCKY POINT DR, PEARLAND, TX 77584-1043, US
PEARLAND, TX, US
CELLULA BIOPHARMA, INC.
From the company
Cellula BioPharma is developing a game changing CAR-T platform technology for solid tumors. The company is developing a Nucleotide Metabolic Reprogramed CAR (designated MR CAR), with efficacy and safety validated using in vitro assays and two different tumor mouse models. Their approach targets adenosine (ADO) inhibition, addressing nutrient starvation of T cells in solid tumors.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.